Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Amoxicillin-Clavulanate to Prevent Bacteremia
NCT02783404Phase 4Terminated
- Sponsor
- Universidad de Santiago de Compostela
- Start
- Feb 2017
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amoxicillin + clavulanate in Bacteremia, sponsored by Universidad de Santiago de Compostela. Started Feb 2017; status: terminated.
02
Drugs
amoxicillin + clavulanate
03
Conditions
Bacteremia
Beyond the preview
Go deeper on NCT02783404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02783404.